Companies / California / Senti Biosciences

· rebuilt nightly from public records

Signal Sheet

Selling to Senti Biosciences? Who to reach and why now

Senti Biosciences is a publicly listed biological products, (no diagnostic substances) company in South San Francisco, California, founded 2021. It raised $37.6M in Dec 2024 and its filings name 8 officers. Everything below links to the record it came from.

Listed company · Biological Products, (No Diagnostic Substances) · California

The easy button for new customers

Lakewave's AI keeps accounts like this one coming. Your pipeline refills while you sleep.

Every night it scans funding, filings, new officers, hiring, contracts, permits and bids, finds the accounts that fit what you sell, and delivers each with outreach and a pursuit plan. Just need a list? Its AI waterfall builds one with verified, reachable contacts.

SourceNew accounts that match what you offer, added as the signals land. The list never runs dry.
Reach outA first email written from why the account is hot, then a drip sequence that follows up until they reply. Sent from your own mailbox, with every open and reply tracked.
PursueAn AI-written plan built from your value proposition and the customer's compelling event: who to call, what to lead with, and the next step to win it. In early access.
Start your free trial →Tell it what you sell and where. Your list stays yours.

Who to reach

The roles that matter for a seller right now. Names on this page come from SEC filings or the company's own announcements. Contacts you find with a free trial are verified before you see them. How we source names

RoleContactSourceWhy they matter now
Executive OfficerTimothy LuSEC filing, Dec 2024Named officer in the filing; part of the buying group
Executive OfficerKanya RajangamSEC filing, Dec 2024Named officer in the filing; part of the buying group
Executive OfficerYvonne LiSEC filing, Dec 2024Named officer in the filing; part of the buying group
Chief Technology OfficerBrenda CooperstoneSEC filing, Dec 2024Technology and tooling decisions
Chief Technology OfficerEdward MathersSEC filing, Dec 2024Technology and tooling decisions
Chief Technology OfficerJames CollinsSEC filing, Dec 2024Technology and tooling decisions
Chief Technology OfficerFran SchulzSEC filing, Dec 2024Technology and tooling decisions
Chief Technology OfficerDonald TangSEC filing, Dec 2024Technology and tooling decisions
For sellersWhy Senti Biosciences is worth a call this quarterBuy Window: open · major agreement Nov 2026
Nov 2026Nov 2026

Corporate event

Signed a material agreement

Corporate event
Oct 26Oct 2026

New leadership

Officer or director change

New leadership
$37.6M

Raised

Equity raise reported to the SEC, Dec 2024. Money arrives before the spending plan does.

Capital
Track Senti Biosciences with a free trial →Get the next signal the day it is filed or posted.
Email me the next Senti Biosciences signalOne email when it files, raises, hires or posts a role. Watch up to 3 companies free, no password.

Why now

The most recent events first, refreshed every night. Each links to the record it came from.

WhenWhat happenedKindSource
Nov 9, 2026Signed a material agreementCorporate eventSEC filing
Oct 26, 2026Officer or director changeNew leadershipSEC filing
Oct 21, 2026Signed a material agreementCorporate eventSEC filing
Oct 21, 2026Completed an acquisition or saleCorporate eventSEC filing
Sep 23, 2026Officer or director changeNew leadershipSEC filing
Sep 3, 2026Signed a material agreementCorporate eventSEC filing
Aug 27, 2026Signed a material agreementCorporate eventSEC filing
Aug 14, 2026Signed a material agreementCorporate eventSEC filing

Reach Senti Biosciences with emails that land

Lakewave finds the right people at Senti Biosciences, checks every address against the mail server before you see it, and drafts a first email for each, which you review and send from your own inbox.

Try it on Senti Biosciences with a free trial →

About Senti Biosciences

HeadquartersSouth San Francisco, California, per the filing address
Industry groupBiological Products, (No Diagnostic Substances)
Founded2021, DE
OwnershipListed company
Raise history$37.6M (Dec 2024)
Lakewave Rising53 · 2 kinds of evidence · rank in California after sign-up

Similar companies

Private-sector companies in the same industry group and state, ranked by Rising score.

Gilead Sciences · 35Revolution Medicines · 35Lycia Therapeutics · 34Liminatus Pharma · 26Jasper Therapeutics · 20Tarsus Pharmaceuticals · 12See all 6 with a free trial →

Questions people ask

Did Senti Biosciences raise funding in 2024?

Yes. Senti Biosciences reported a $37.6M equity raise to the SEC on Dec 9, 2024 with 15 investors.

Who runs Senti Biosciences?

The company's SEC filing, Dec 2024 names Timothy Lu (Executive Officer) among its officers.

Where is Senti Biosciences headquartered?

South San Francisco, California, per the address on its SEC filing.

Know who is buying before the first callStart your free trial →

Know who is buying before the first call

Select the accounts and territory you sell to and get dated reasons for every company: new budget, new leaders, new hires, with who to reach and a first draft for each contact.

Start your free trial

Compiled from public records and refreshed nightly; last updated Nov 16, 2026. Facts are as the SEC, the company's careers page or the company's own announcements published them. Check the source before acting. See something wrong? Tell us and we will correct it.